Viridien
CGPVF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $523 | $521 | $521 | $6 |
| - Cash | $2,263 | $162 | $147 | $302 |
| + Debt | $12,023 | $1,158 | $1,076 | $1,223 |
| Enterprise Value | $10,283 | $1,517 | $1,451 | $927 |
| Revenue | $267 | $234 | $258 | $427 |
| % Growth | 14.1% | -9% | -39.6% | – |
| Gross Profit | $107 | $44 | $87 | $142 |
| % Margin | 40% | 18.9% | 33.6% | 33.4% |
| EBITDA | $125 | $87 | $53 | $105 |
| % Margin | 46.7% | 37.1% | 20.7% | 24.6% |
| Net Income | $41 | $6 | -$28 | $29 |
| % Margin | 15.4% | 2.3% | -10.8% | 6.7% |
| EPS Diluted | 5.71 | 0.77 | -3.87 | 3.99 |
| % Growth | 641.6% | 119.9% | -197% | – |
| Operating Cash Flow | $127 | $104 | $91 | $159 |
| Capital Expenditures | -$10 | $44 | -$61 | -$81 |
| Free Cash Flow | $117 | $148 | $29 | $78 |